Rznomics Secures Third Research Payment from Eli Lilly, Signaling Robust Progress in Hereditary Hearing Loss RNA-Editing Collaboration
SEONGNAM, SOUTH KOREA – Rznomics, a South Korean biotechnology company, has received an additional research payment from Eli Lilly and Company, marking the third such installment under their ongoing global…
